China Biotech Services Holdings Ltd

08037

Company Profile

  • Business description

    China Biotech Services Holdings Ltd is an investment holding company. It operates through five segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Insurance brokerage, BNCT, and Others. It derives prime revenue from the Medical & health-related services segment, which involves the provision of medical laboratory testing & health check services. The group has a business presence in Hong Kong & the PRC, of which key revenue is generated from Hong Kong. Immunotherapy-provision of tumor immune cell therapy & health management services. Pharmaceutical products-sale & distribution of health-related & pharmaceutical products. Insurance brokerage services. BNCT-provision of boron neutron capture therapy treatment services, & Others-provision of logistic services.

  • Contact

    255-257 Gloucester Road
    Suites 1904-05A, 19th Floor, Sino Plaza
    Causeway Bay
    Hong Kong
    HKG

    T: +852 31883333

    http://www.cbshhk.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    149

Stocks News & Analysis

stocks

Expanding store network for ASX listed retailer

Sales growth but lack of margin expansion due to competition.
stocks

3 cheap fully franked stocks

Discounted Aussie shares that offer a tax rebate.
stocks

SpaceX jumps 19% in debut, but hurdles lie ahead

Pre-IPO holders could start selling later this summer, and earnings will be an important test.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,128.0014.600.16%
CAC 408,384.0133.140.40%
DAX 4024,894.01258.711.05%
Dow JONES (US)51,671.03468.770.92%
FTSE 10010,430.6241.10-0.39%
HKSE24,842.67124.570.50%
NASDAQ26,683.94795.103.07%
Nikkei 22569,317.503,297.464.99%
NZX 50 Index13,360.5933.28-0.25%
S&P 5007,554.29122.831.65%
S&P/ASX 2008,914.007.000.08%
SSE Composite Index4,096.4764.961.61%

Market Movers